Search Results 31-40 of 10411 for Heart failure with preserved ejection fraction
The combination medicine is sacubitril-valsartan (Entresto). It's used to treat some people with heart failure with reduced ejection fraction. It may help ...
The enormous and rapidly growing burden of Heart Failure with Preserved Ejection Fraction (HFpEF) has led to a need to understand the pathogenesis and ...
A Study to Evaluate the Prevalence of Transthyretin Cardiac Amyloidosis in Heart Failure Patients with Preserved Ejection Fraction in Southeastern Minnesota.
It is common to use left ventricular ejection fraction as a way to determine prognosis. We have found this is not always the best way to determine prognosis in ...
Determine the impact of restoring normal heart rate response during exercise and daily activity in patients with heart failure and a preserved ejection fraction ...
... cardiac blood flow) in patients with heart failure with preserved ejection fraction (HFpEF). Participation eligibility. Participant eligibility includes age ...
The purpose of this study is to compare myocardial stiffness between subjects with and without heart failure with preserved ejection fraction (HFpEF).
... Heart Failure With Preserved Ejection Fraction And Pulmonary Vascular Disease ... failure with preserved ejection fraction (HFpEF) and pulmonary vascular disease ...
The primary hypothesis is that patients with HFREF (heart failure with reduced ejection fraction) will demonstrate a markedly expanded intravascular volume ...
Study To Evaluate The Safety And Effectiveness Of IW-1973 Dosing Over 12 Weeks In Patients With Congestive Heart Failure With Preserved Ejection Fraction.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.